United Health Products, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 10:15 am EST
Share
United Health Products, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.0375 million. Net income was USD 0.820567 million compared to net loss of USD 0.724416 million a year ago.
For the nine months, sales was USD 0.0375 million compared to USD 0.000059 million a year ago. Net loss was USD 1.02 million compared to USD 29.08 million a year ago.
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze for the healthcare and wound care sectors. Its gauze product, HemoStyp, is a neutralized, oxidized, regenerated cellulose (NORC) derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. Its hemostatic gauze is a collagen-like natural substance created from chemically treated cellulose derived from cotton is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The material is folded to fit the size of the wound. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis.
UNITED HEALTH PRODUCTS, INC. 
